Lupus and Skin: What Dermatologists Look For in New Braunfels Patients

The skin is often where lupus shows itself first. A rash that flares after a weekend on the river, thick scaly patches along the hairline, hair that thins and does not grow back, sores on the roof of the mouth — these are the findings that bring people to a dermatologist months or years before joint pain and fatigue ever get a name. If you have noticed any of them, an evaluation of your lupus skin symptoms by a New Braunfels dermatologist is a reasonable next step, because the skin is one of the few places where this disease can be seen, photographed, and biopsied.

Cutaneous lupus is not one condition

“Lupus” is a family of diseases, not a single diagnosis. According to the American Academy of Dermatology, when lupus affects the skin it is called cutaneous lupus — and you can have cutaneous lupus with or without systemic lupus erythematosus (SLE), the more widely known form that can involve the joints, kidneys, blood, and other organs.

The clinical framework dermatologists still use was set out by Gilliam and Sontheimer in 1981, dividing cutaneous lupus into acute, subacute, and chronic subsets:

Acute cutaneous lupus (ACLE). The butterfly rash is the prototype — symmetric redness across the cheeks and the bridge of the nose, characteristically sparing the smile lines. It usually follows sun exposure and clears without scarring, though it can leave darker patches behind. The AAD notes that a butterfly rash can be the first visible sign that lupus is affecting more than the skin, which is why it should never be written off as sunburn or adult acne.

Subacute cutaneous lupus (SCLE). Ring-shaped patches with raised crusted borders, or a widespread scaly rash that can be mistaken for psoriasis or eczema. It is strongly sun-driven and is associated with anti-Ro/SSA antibodies. It can also be triggered by medications — hydrochlorothiazide, calcium channel blockers, terbinafine, and TNF inhibitors are recognized culprits — so a full medication history is part of every workup.

Discoid lupus (DLE). The most common form of cutaneous lupus. Firm, disc-shaped, thick and scaly patches on the face, ears, and scalp, with an inflamed border and a pale, thinned center. Unlike the butterfly rash, discoid lesions scar. On the scalp that scarring destroys hair follicles permanently. The AAD also notes that patients with darker skin tones tend to develop more scarring and pigment change, and that long-standing untreated discoid lupus may raise the risk of skin cancer in those scars.

Several less common forms round out the group — lupus tumidus, lupus panniculitis, and chilblain lupus among them.

How often does discoid lupus become systemic lupus?

This is the question patients ask first, and the honest answer is higher than older patient handouts suggest. A 2025 systematic review of 2,814 patients across 72 studies found progression from discoid lupus to SLE in 25.4% of adults and 30.0% of pediatric patients. The risk factors it identified were early-onset disease, ANA positivity, high ANA titers (1:320 or above), and a family history of rheumatic disease.

Timing matters too. A Brigham and Women’s cohort study found a median time to progression of just 453 days — far sooner than the roughly eight years older reports had described. Practically, that means a discoid lupus diagnosis earns real follow-up in the first two years, not a reassurance and a five-year gap.

The other skin findings worth knowing

Sun sensitivity. Abnormal reactivity to ultraviolet light is among the most clinically important features of lupus, and it is not limited to the rash itself — sun exposure can set off systemic flares. This is disease management, not vanity.

Hair loss. Two different mechanisms. Diffuse thinning during a flare usually recovers. Scarring from active discoid plaques on the scalp does not, which makes early scalp treatment urgent. If your hair loss is patchy and the scalp looks normal, a different diagnosis such as alopecia areata may be in play — the distinction is made by examination and, when needed, biopsy.

Mouth and nose sores. Often painless, often on the palate, and often missed by the patient entirely. We look for them.

Vascular findings. Livedo reticularis (a lacy purple mottling), palpable purpura, digital ulcers, and dilated vessels at the nail folds all point toward vessel involvement. Raynaud’s phenomenon — fingers turning white, then blue, then red with cold or stress — commonly travels with lupus and other connective tissue diseases.

What a dermatologic evaluation actually involves

The first step is examination: the morphology, the distribution, whether lesions scar, whether they sit on sun-exposed skin. Much of the diagnosis lives in those details, which is why photographs and an in-person exam beat a description over the phone.

When the picture is unclear, a punch biopsy settles it. Routine staining shows the interface inflammation characteristic of lupus; direct immunofluorescence can demonstrate the “lupus band” — immunoglobulin and complement deposits at the junction between epidermis and dermis. Biopsies are done in the office, and what to expect at a visit like this is covered in our guide to your first dermatology appointment.

Bloodwork is ordered and interpreted alongside rheumatology: ANA, anti-dsDNA, anti-Smith, anti-Ro/SSA, anti-La/SSB, complement levels, and a complete blood count. One caution worth repeating — a positive ANA by itself does not mean lupus. Low-titer positive ANAs are common in people who are perfectly well. Titer, pattern, and clinical findings have to be read together. The current EULAR/ACR classification criteria use a positive ANA only as an entry point, with weighted clinical and immunologic criteria on top of it.

Because a facial rash has a long differential, part of the evaluation is ruling things out: rosacea and perioral dermatitis both produce central facial redness and are far more common than lupus.

Sun protection is treatment

The evidence here is unusually clean. In a randomized, vehicle-controlled, double-blind study of 25 patients with photosensitive cutaneous lupus, researchers deliberately irradiated skin with UVA and UVB under standardized conditions. Lesions appeared in untreated and vehicle-treated areas — and in none of the 25 patients on the sunscreen-treated area. A highly protective broad-spectrum sunscreen prevented the lesions outright.

What that looks like day to day:

• Broad-spectrum SPF 50+ every morning, cloudy days included — UVA passes through window glass and windshields
• Mineral filters (zinc oxide, titanium dioxide) are a sensible default for reactive skin; our Texas sunscreen guide covers how to choose one you will actually wear
• UPF 50+ clothing and a wide-brimmed hat for time outdoors
• Shade between roughly 10 AM and 4 PM

In Comal County, where the calendar runs on tubing, ball fields, and back porches, this is the hardest part of the plan and the one that pays off most.

Treatment options

Hydroxychloroquine is the backbone of cutaneous lupus treatment — it reduces photosensitivity, suppresses flares, and is generally considered protective against progression. Most patients with cutaneous lupus should be evaluated for it unless there is a reason not to. It requires periodic eye monitoring.

Topical corticosteroids are first-line for active lesions, with potency matched to the site — milder on the face, stronger on the trunk and scalp.

Topical calcineurin inhibitors (tacrolimus, pimecrolimus) avoid the skin-thinning risk of steroids on facial skin. In a multicenter randomized trial of tacrolimus 0.1% ointment, treated lesions improved significantly at 28 and 56 days compared with vehicle, with swelling responding fastest; the benefit was clearest in acute, swollen, non-thickened lesions rather than thick discoid plaques, and was not significant by day 84. Useful, in other words, for the right lesion at the right time.

For resistant disease, quinacrine added to hydroxychloroquine, dapsone, methotrexate, and mycophenolate are used in coordination with rheumatology. Newer systemic agents approved for SLE may help skin findings as well.

Related reading

• Raynaud’s Phenomenon: Why Your Fingers Change Color
• Alopecia Areata: Causes, Symptoms, and Treatment Options
• Rosacea Treatment in New Braunfels: What Actually Works
• A Dermatologist’s Guide to Choosing and Using Sunscreen in Texas
• What Happens at Your First Dermatology Visit
• Does Insurance Cover Dermatology in Texas?

References

1. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4(4):471–475. PubMed
2. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–1412. PubMed
3. Kuhn A, Gensch K, Haust M, et al. Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study. J Am Acad Dermatol. 2011;64(1):37–48. PubMed
4. Kuhn A, Gensch K, Haust M, et al. Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial. J Am Acad Dermatol. 2011;65(1):54–64. PubMed
5. Alharbi A, Alamri O, Afandi A, et al. Discoid lupus erythematosus and its progression to systemic lupus erythematosus across age groups: a systematic review. J Med Life. 2025;18(9):830–836. PubMed
6. Elman SA, Joyce C, Costenbader KH, Merola JF. Time to progression from discoid lupus erythematosus to systemic lupus erythematosus: a retrospective cohort study. Clin Exp Dermatol. 2020;45(1):89–91. PubMed
7. American Academy of Dermatology. Lupus and your skin: overview. AAD.org

A rash that flares in the sun, scaly patches that scar, or hair loss that does not grow back are all worth a look — and when lupus is the answer, finding it early changes what happens next. The board-certified dermatologists at Elect Dermatology in New Braunfels evaluate cutaneous lupus, perform in-office biopsies when indicated, and work directly with your rheumatologist. Call (833) 353-2875 to schedule at 2154 Gabriels Pl, Ste 103, New Braunfels, TX 78130.

Reviewed by Dr. Stahr